Arash Nabbi

Scientific Associate I. University Health Network, Toronto, ON.

prof_pic.jpg

Princess Margaret Cancer Research Tower

101 College street

Toronto, ON, M5G 1L7

I am a pharmacist and cancer biologist with post-doctoral experience in computational genomics. I strive to become a translational scientist to improve cancer care through personalized immunotherapy. I am interested in applying advanced technologies to identify molecular mechanisms of therapy resistance and predictive biomarkers for immunotherapy.

Research interests:
  • Predictive immune biomarkers to guide prospective clinical trials
  • Identification of novel targets of cancer immunotherapy using a combination of computational and experimental approaches
  • Tumour-Immune evolution over course of disease/treatment

I am currently a research fellow in Dr. Trevor Pugh’s laboratory at the Princess Margaret Cancer Center located in Toronto, ON. Here, I have had the opportunity to work on several translational research projects focused on the immunogenomics of pediatric cancers. I am an active member of PRecision Oncology For Young people (PROFYLE) and the recently announced Canadian Pediatric Cancer Consortium (CPCC), two national networks that aim to provide precision medicine for all Canadian children suffering from hard-to-treat cancers.

Post-doctoral projects:

I hold a PhD in cancer biology from the Cumming school of medicine at the University of Calgary. During my studies, I focused on investigating epigenetic and post-translational regulation of Androgen Receptor pathway and its impact on the progression of prostate cancer.

news

Sep 11, 2023 Thrilled to announce that my postdoctoral work on immunogenomic analysis of pediatric CNS tumors and neurobastomas is now online at Genome Medicine. I would like to thank collaborators at the German Cancer Center (DKFZ), Children’s Hospital of Philadelphia, and members of the PROFYLE program in Canada for their help and input during this project. Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours
Apr 28, 2023 Great to have my work highlighted in the News & Views section of Nature Cancer. Appreciate authors Drs. Neeson & Ekert! Harnessing immune checkpoint trial data in pediatric cancer
Apr 20, 2023 Thrilled to see my work on biomarker analysis of pediatric tumors treated with atezolizumab online in Nature Cancer. I would like to thank collaborators at Genentech/Roche as well as funders for this important study highlighting the value of personalized immunotherapy in pediatric cancers. Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Nov 24, 2022 Listen to me presenting our recent preprint at the CBTN scientific summit 2022, Washington, DC. Transcriptional analysis identifies distinct immune clusters in pediatric nervous system tumours
Sep 22, 2022 The preprint of my post-doctoral work is now on-line: Transcriptional immunogenomic analysis reveals distinct immunological clusters in pediatric nervous system tumours